News

Published on 2 Oct 2023 on Market Watch

SmileDirectClub shares plunge after bankruptcy filing, with Syndax and AMC shares climbing and other...


Article preview image

Here are the biggest movers ahead of Monday’s market open:

NASDAQ.SNDX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA

Syndax Pharmaceuticals SNDX stock rose 7.6% on Mar 27 after it announced a day before that the FD...

Zacks via Yahoo Finance 28 Mar 2024

Zymeworks adds Dr. Neil Gallagher to its board of directors By Investing.com

Dr. Gallagher, with more than two decades of experience in the pharmaceutical and biotechnology...

Investing.com 27 Mar 2024

Syndax Announces FDA Priority Review of NDA for Revumenib for the Treatment of Relapsed/Refractory...

Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...

WCMH Columbus 26 Mar 2024

FDA grants priority review for Syndax leukemia drug, sets action date (NASDAQ:SNDX)

Syndax (SNDX) said the FDA has granted Priority Review status for its market application for...

Seeking Alpha 26 Mar 2024

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2023 Earnings Call Transcript

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2023 Earnings Call Transcript February 27, 2024 Syn...

Insider Monkey via Yahoo Finance 3 Mar 2024

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an...

FOX 23 News Albany 1 Mar 2024

With 85% ownership of the shares, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is heavily dominated by...

Key Insights Institutions' substantial holdings in Syndax Pharmaceuticals implies that they have ...

Simply Wall St. via Yahoo Finance 23 Dec 2023

12 Most Promising Cancer Stocks According to Analysts

In this piece, we will take a look at the 12 most promising cancer stocks according to analysts. ...

Insider Monkey via Yahoo Finance 18 Dec 2023

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Could Be 49% Below Their Intrinsic Value Estimate

Key Insights Using the 2 Stage Free Cash Flow to Equity, Syndax Pharmaceuticals fair value estima...

Simply Wall St. via Yahoo Finance 7 Nov 2023

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2023 Earnings Call Transcript

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2023 Earnings Call Transcript November 2, 2023 Synd...

Insider Monkey via Yahoo Finance 3 Nov 2023